In parallel, Debio 1143 showed an improved efficacy in preventing tumor growth compared to vehicle and paclitaxel after 1 and 2 weeks of treatment and remained 1 week after treatment arrest confirming the predictive value of 99mTc-HYNIC-Annexin V tumor uptake on therapy efficacy. Here, ANXA5 is linked to neoplasm.